homefeedbacksupportlog on 2-Dec-2008 
  Search
 
   
 
  Browse
ALL OF MEDICINE

Dermatology
Acne-Like Disorders
Acquired & Inherited Bullous Disorders
Atopic Dermatitis & Other Forms of Eczema
Cutaneous Signs of Systemic Disease
Dermatologic & Cosmetic Surgery
Dermatologic Pathology
Drug Eruptions
Hair Diseases
Nail Diseases
Pediatric Skin Diseases (inc. Genetic Diseases)
Photodermatology & Skin Ageing
Pigmentary Disorders
Psoriasis & Other Inflammatory Diseases
Skin Cancers (inc. Melanoma & Lymphoma)
Skin Infections (inc. STDs)
Urticaria, Vasculitis & Connective Tissue Disease

profile subject selected for My F1000 Medicine

Browse > Dermatology > Psoriasis & Other Inflammatory Diseases
Current Top 10 by F1000 Factor / All Time Top 10 by F1000 Factor / Most viewed
(from all journals) / Most viewed
(from specialty journals) / Hidden jewels		Page 1 of 4. Select Page: 1 2 3 4 >>
Display 10 / 20 / 50 papers per page

printer friendly 
to email [Help]

Must Read
F1000 Factor 6.0

Confirmation
 Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
Hearn RM, Kerr AC, …, Ferguson J, Dawe RS
Br J Dermatol 2008 Sep 159(4):931-5 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Melvin Chiu
Evaluated 26 Nov 2008

Recommended
F1000 Factor 3.0

New Finding
 Genetic Variants of the IL-23R Pathway: Association with Psoriatic Arthritis and Psoriasis Vulgaris, but No Specific Risk Factor for Arthritis.
Hüffmeier U, Lascorz J, …, Burkhardt H, Reis A
J Invest Dermatol 2008 Sep 18 [abstract on PubMed] [related articles] [full text]
Selected by | Johann Gudjonsson with John Yost
Evaluated 11 Nov 2008

Must Read
F1000 Factor 6.0

New Finding
 Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway.
Cao W, Manicassamy S, …, Murthy N, Pulendran B
Nat Immunol 2008 Oct 9(10):1157-64 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Frank Nestle with Gayathri K Perera
Evaluated 21 Oct 2008


Recommended
F1000 Factor 3.0

New Finding
 Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses.
Denning TL, Wang YC, …, Williams IR, Pulendran B
Nat Immunol 2007 Oct 8(10):1086-94 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Michelle Lowes with Kristine E Nograles
Evaluated 21 Oct 2008


Recommended
F1000 Factor 3.0

New Finding
 The role of narrowband UV-B plus alefacept combination therapy in the treatment of psoriasis.
Jacobe H, Winterfield L, …, Huet-Adams B, Cayce R
Arch Dermatol 2008 Aug 144(8):1067-8; author reply 1068-9 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Robert Dawe
Evaluated 3 Oct 2008

Recommended
F1000 Factor 3.0

Hypothesis
 Vitamin D regulation of cathelicidin in the skin: toward a renaissance of vitamin D in dermatology?
Segaert S
J Invest Dermatol 2008 Apr 128(4):773-5 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Frank Powell with Maeve McAleer
Evaluated 24 Sep 2008

Recommended
F1000 Factor 3.0

Confirmation
New Finding
 Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.
Nograles KE, Zaba LC, …, Lowes MA, Krueger JG
Br J Dermatol 2008 Aug 5 [abstract on PubMed] [related articles] [full text]
Selected by | Johann Gudjonsson
Evaluated 3 Sep 2008

Exceptional
F1000 Factor 9.0

New Finding
 Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.
Wollina U, Hansel G, …, Köstler E, Haroske G
Am J Clin Dermatol 2008 9(1):1-14 [abstract on PubMed] [related articles] [order article]
Selected by | Bianca Maria Piraccini
Evaluated 2 Sep 2008

Must Read
F1000 Factor 6.0
Articles that inform your practice or change your way of thinking Changes
Clinical Practice

Controversial
 Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis.
Viguier M, Richette P, …, Bardin T, Bachelez H
Arthritis Rheum 2008 Jun 58(6):1796-802 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Dafna Gladman with Vinod Chandran
Evaluated 13 Aug 2008

Must Read
F1000 Factor 6.0

New Finding
 Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma.
Mielke F, Schneider-Obermeyer J, Dörner T
Ann Rheum Dis 2008 Jul 67(7):1056-7 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Nikhil Yawalkar
Evaluated 13 Aug 2008


top of pagePage 1 of 4. Select Page: 1 2 3 4 >>
Display 10 / 20 / 50 papers per page

© 2008 Medicine Reports Ltd unless otherwise stated. < info@f1000.com >   Terms and conditions   Legal info